Naga Chalasani

5PUBLICATIONS
11CO-AUTHORS
Respiratory diseasesEpidemiological methodsPredictive and prognostic markersFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 10, 2022
Letter: non-invasive prediction models to exclude cirrhosis in NAFLD-not everyone fits the mould. Authors' reply.

Danielle Brandman, Marie Boyle, Stuart McPherson

|Sep 21, 2020
Clinical Characteristics and Outcomes of Mild to Moderate Alcoholic Hepatitis.

Niharika Samala, Samer Gawrieh, Qing Tang

|Sep 19, 2019
Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply.

Eduardo Vilar-Gomez, Naga Chalasani

|Sep 19, 2019
Letter: metformin treatment and hepatocellular carcinoma risk in non-alcoholic fatty liver disease. Authors' reply.

Eduardo Vilar-Gomez, Naga Chalasani

|Jun 04, 2019
Long-term metformin use may improve clinical outcomes in diabetic patients with non-alcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis.

Eduardo Vilar-Gomez, Raj Vuppalanchi, Archita P Desai

Pageof 1